☰

Jeffrey M. Trent - Publications

Affiliations: 
The Translational Genomics Research Institute (TGen) 
Tree Info Similar researchers PubMed Report error

39 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Zhu X, Fu Z, Chen SY, Ong D, Aceto G, Ho R, Steinberger J, Monast A, Pilon V, Li E, Ta M, Ching K, Adams BN, Negri GL, Choiniere L, ... ... Trent J, et al. Alanine supplementation exploits glutamine dependency induced by SMARCA4/2-loss. Nature Communications. 14: 2894. PMID 37210563 DOI: 10.1038/s41467-023-38594-3  0.347
2021 Halperin RF, Hegde A, Lang JD, Raupach EA, Legendre C, Liang WS, LoRusso PM, Sekulic A, Sosman JA, Trent JM, Rangasamy S, Pirrotte P, Schork NJ. Improved methods for RNAseq-based alternative splicing analysis. Scientific Reports. 11: 10740. PMID 34031440 DOI: 10.1038/s41598-021-89938-2  0.587
2020 Orlando KA, Douglas AK, Abudu A, Wang Y, Tessier-Cloutier B, Su W, Peters A, Sherman LS, Moore R, Nguyen V, Negri GL, Colborne S, Morin GB, Kommoss F, Lang JD, ... ... Trent JM, et al. Re-expression of SMARCA4/BRG1 in Small Cell Carcinoma of Ovary, Hypercalcemic Type (SCCOHT) promotes an epithelial-like gene signature through an AP-1-dependent mechanism. Elife. 9. PMID 33355532 DOI: 10.7554/eLife.59073  0.656
2020 Karnezis AN, Chen SY, Chow C, Yang W, Hendricks WPD, Ramos P, Briones N, Mes-Masson AM, Bosse T, Gilks CB, Trent JM, Weissman B, Huntsman DG, Wang Y. Re-assigning the histologic identities of COV434 and TOV-112D ovarian cancer cell lines. Gynecologic Oncology. PMID 33328126 DOI: 10.1016/j.ygyno.2020.12.004  0.415
2020 Soldi R, Ghosh Halder T, Weston A, Thode T, Drenner K, Lewis R, Kaadige MR, Srivastava S, Daniel Ampanattu S, Rodriguez Del Villar R, Lang J, Vankayalapati H, Weissman B, Trent JM, Hendricks WPD, et al. The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancer. Plos One. 15: e0235705. PMID 32649682 DOI: 10.1371/Journal.Pone.0235705  0.666
2020 Ji JX, Cochrane DR, Tessier-Cloutier B, Chen SY, Ho G, Pathak KV, Alcazar IN, Farnell D, Leung S, Cheng A, Chow C, Colborne S, Negri GL, Kommoss F, Karnezis A, ... ... Trent JM, et al. Arginine depletion therapy with ADI-PEG20 limits tumor growth in argininosuccinate synthase deficient ovarian cancer, including small cell carcinoma of the ovary, hypercalcemic type. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32409304 DOI: 10.1158/1078-0432.Ccr-19-1905  0.446
2020 Tischkowitz M, Huang S, Banerjee S, Hague J, Hendricks WPD, Huntsman DG, Lang JD, Orlando KA, Oza AM, Pautier P, Ray-Coquard I, Trent JM, Wichter M, Witkowski L, McCluggage WG, et al. Small Cell Carcinoma of the Ovary, Hypercalcaemic Type - genetics, new treatment targets and current management guidelines. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32156746 DOI: 10.1158/1078-0432.Ccr-19-3797  0.635
2019 Gardner HL, Sivaprakasam K, Briones N, Zismann V, Perdigones N, Drenner K, Facista S, Richholt R, Liang W, Aldrich J, Trent JM, Shields PG, Robinson N, Johnson J, Lana S, et al. Canine osteosarcoma genome sequencing identifies recurrent mutations in and the histone methyltransferase gene . Communications Biology. 2: 266. PMID 31341965 DOI: 10.1038/s42003-019-0487-2  0.301
2018 Wang Y, Chen SY, Colborne S, Lambert G, Shin CY, Dos Santos N, Orlando KA, Lang JD, Hendricks WPD, Bally MB, Karnezis AN, Hass R, Underhill TM, Morin GB, Trent JM, et al. Histone deacetylase inhibitors synergizes with catalytic inhibitors of EZH2 to exhibit anti-tumor activity in small cell carcinoma of the ovary, hypercalcemic type. Molecular Cancer Therapeutics. PMID 30232145 DOI: 10.1158/1535-7163.Mct-18-0348  0.673
2018 Lang JD, Hendricks WPD, Orlando KA, Yin H, Kiefer J, Ramos P, Sharma R, Pirrotte P, Raupach EA, Sereduk C, Tang N, Liang WS, Washington M, Facista SJ, Zismann VL, ... ... Trent JM, et al. Ponatinib shows potent antitumor activity in small cell carcinoma of the ovary hypercalcemic type (SCCOHT) through multi-kinase inhibition. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29440177 DOI: 10.1158/1078-0432.Ccr-17-1928  0.638
2017 Cornelius A, Foley J, Bond J, Nagulapally AB, Steinbrecher J, Hendricks WPD, Rich M, Yendrembam S, Bergendahl G, Trent JM, Sholler GS. Molecular Guided Therapy Provides Sustained Clinical Response in Refractory Choroid Plexus Carcinoma. Frontiers in Pharmacology. 8: 652. PMID 28993730 DOI: 10.3389/fphar.2017.00652  0.306
2017 Wang Y, Chen SY, Karnezis AN, Colborne S, Santos ND, Lang JD, Hendricks WPD, Orlando KA, Yap D, Kommoss F, Bally MB, Morin GB, Trent JM, Weissman BE, Huntsman DG. The histone methyltransferase EZH2 is a therapeutic target in small cell carcinoma of the ovary, hypercalcemic type. The Journal of Pathology. PMID 28444909 DOI: 10.1002/Path.4912  0.686
2017 Zhang T, Xu M, Makowski MM, Lee C, Kovacs M, Fang J, Willems E, Trent JM, Hayward NK, Vermeulen M, Brown KM. SDHD promoter mutations ablate GABP transcription factor binding in melanoma. Cancer Research. PMID 28108517 DOI: 10.1158/0008-5472.Can-16-0919  0.319
2016 Kang HJ, Cui Y, Yin H, Scheid A, Hendricks WP, Schmidt J, Sekulic A, Kong D, Trent JM, Gokhale V, Mao H, Hurley LH. A Pharmacological Chaperone Molecule Induces Cancer Cell Death by Restoring Tertiary DNA Structures in Mutant hTERT Promoters. Journal of the American Chemical Society. PMID 27643954 DOI: 10.1021/Jacs.6B07598  0.389
2016 Witkowski L, Goudie C, Ramos P, Boshari T, Brunet JS, Karnezis AN, Longy M, Knost JA, Saloustros E, McCluggage WG, Stewart CJ, Hendricks WP, Cunliffe H, Huntsman DG, Pautier P, ... ... Trent JM, et al. The influence of clinical and genetic factors on patient outcome in small cell carcinoma of the ovary, hypercalcemic type. Gynecologic Oncology. PMID 26975901 DOI: 10.1016/j.ygyno.2016.03.013  0.314
2015 Karnezis AN, Wang Y, Ramos P, Hendricks WP, Oliva E, D'Angelo E, Prat J, Nucci MR, Nielsen TO, Chow C, Leung S, Kommoss F, Kommoss S, Silva A, Ronnett BM, ... ... Trent JM, et al. Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcemic type. The Journal of Pathology. PMID 26356327 DOI: 10.1002/Path.4633  0.492
2014 Ramos P, Karnezis AN, Hendricks WP, Wang Y, Tembe W, Zismann VL, Legendre C, Liang WS, Russell ML, Craig DW, Farley JH, Monk BJ, Anthony SP, Sekulic A, Cunliffe HE, ... ... Trent JM, et al. Loss of the tumor suppressor SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT). Rare Diseases (Austin, Tex.). 2: e967148. PMID 26942101 DOI: 10.4161/2167549X.2014.967148  0.46
2014 Goodall ML, Wang T, Martin KR, Kortus MG, Kauffman AL, Trent JM, Gately S, MacKeigan JP. Development of potent autophagy inhibitors that sensitize oncogenic BRAF V600E mutant melanoma tumor cells to vemurafenib. Autophagy. 10: 1120-36. PMID 24879157 DOI: 10.4161/Auto.28594  0.329
2014 Ramos P, Karnezis AN, Craig DW, Sekulic A, Russell ML, Hendricks WP, Corneveaux JJ, Barrett MT, Shumansky K, Yang Y, Shah SP, Prentice LM, Marra MA, Kiefer J, Zismann VL, ... ... Trent JM, et al. Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4. Nature Genetics. 46: 427-9. PMID 24658001 DOI: 10.1038/Ng.2928  0.472
2013 Aoude LG, Wadt K, Bojesen A, Crüger D, Borg A, Trent JM, Brown KM, Gerdes AM, Jönsson G, Hayward NK. A BAP1 mutation in a Danish family predisposes to uveal melanoma and other cancers. Plos One. 8: e72144. PMID 23977234 DOI: 10.1371/Journal.Pone.0072144  0.329
2013 Craig DW, O'Shaughnessy JA, Kiefer JA, Aldrich J, Sinari S, Moses TM, Wong S, Dinh J, Christoforides A, Blum JL, Aitelli CL, Osborne CR, Izatt T, Kurdoglu A, Baker A, ... ... Trent JM, et al. Genome and transcriptome sequencing in prospective metastatic triple-negative breast cancer uncovers therapeutic vulnerabilities. Molecular Cancer Therapeutics. 12: 104-16. PMID 23171949 DOI: 10.1158/1535-7163.Mct-12-0781  0.367
2012 Wadt K, Choi J, Chung JY, Kiilgaard J, Heegaard S, Drzewiecki KT, Trent JM, Hewitt SM, Hayward NK, Gerdes AM, Brown KM. A cryptic BAP1 splice mutation in a family with uveal and cutaneous melanoma, and paraganglioma. Pigment Cell & Melanoma Research. 25: 815-8. PMID 22889334 DOI: 10.1111/Pcmr.12006  0.313
2011 Henderson MC, Gonzales IM, Arora S, Choudhary A, Trent JM, Von Hoff DD, Mousses S, Azorsa DO. High-throughput RNAi screening identifies a role for TNK1 in growth and survival of pancreatic cancer cells. Molecular Cancer Research : McR. 9: 724-32. PMID 21536687 DOI: 10.1158/1541-7786.MCR-10-0436  0.35
2011 Li XJ, Ong CK, Cao Y, Xiang YQ, Shao JY, Ooi A, Peng LX, Lu WH, Zhang Z, Petillo D, Qin L, Bao YN, Zheng FJ, Chia CS, Iyer NG, ... ... Trent JM, et al. Serglycin is a theranostic target in nasopharyngeal carcinoma that promotes metastasis. Cancer Research. 71: 3162-72. PMID 21289131 DOI: 10.1158/0008-5472.CAN-10-3557  0.381
2010 Sekulic A, Kim SY, Hostetter G, Savage S, Einspahr JG, Prasad A, Sagerman P, Curiel-Lewandrowski C, Krouse R, Bowden GT, Warneke J, Alberts DS, Pittelkow MR, DiCaudo D, Nickoloff BJ, ... Trent JM, et al. Loss of inositol polyphosphate 5-phosphatase is an early event in development of cutaneous squamous cell carcinoma. Cancer Prevention Research (Philadelphia, Pa.). 3: 1277-83. PMID 20876729 DOI: 10.1158/1940-6207.Capr-10-0058  0.343
2008 Amundson SA, Do KT, Vinikoor LC, Lee RA, Koch-Paiz CA, Ahn J, Reimers M, Chen Y, Scudiero DA, Weinstein JN, Trent JM, Bittner ML, Meltzer PS, Fornace AJ. Integrating global gene expression and radiation survival parameters across the 60 cell lines of the National Cancer Institute Anticancer Drug Screen. Cancer Research. 68: 415-24. PMID 18199535 DOI: 10.1158/0008-5472.Can-07-2120  0.345
2007 Dissanayake SK, Wade M, Johnson CE, O'Connell MP, Leotlela PD, French AD, Shah KV, Hewitt KJ, Rosenthal DT, Indig FE, Jiang Y, Nickoloff BJ, Taub DD, Trent JM, Moon RT, et al. The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition. The Journal of Biological Chemistry. 282: 17259-71. PMID 17426020 DOI: 10.1074/Jbc.M700075200  0.357
2005 Nickoloff BJ, Hendrix MJ, Pollock PM, Trent JM, Miele L, Qin JZ. Notch and NOXA-related pathways in melanoma cells. The Journal of Investigative Dermatology. Symposium Proceedings / the Society For Investigative Dermatology, Inc. [and] European Society For Dermatological Research. 10: 95-104. PMID 16363061 DOI: 10.1111/J.1087-0024.2005.200404.X  0.357
2005 Seftor EA, Brown KM, Chin L, Kirschmann DA, Wheaton WW, Protopopov A, Feng B, Balagurunathan Y, Trent JM, Nickoloff BJ, Seftor RE, Hendrix MJ. Epigenetic transdifferentiation of normal melanocytes by a metastatic melanoma microenvironment. Cancer Research. 65: 10164-9. PMID 16288000 DOI: 10.1158/0008-5472.Can-05-2497  0.37
2005 Qin JZ, Ziffra J, Stennett L, Bodner B, Bonish BK, Chaturvedi V, Bennett F, Pollock PM, Trent JM, Hendrix MJ, Rizzo P, Miele L, Nickoloff BJ. Proteasome inhibitors trigger NOXA-mediated apoptosis in melanoma and myeloma cells. Cancer Research. 65: 6282-93. PMID 16024630 DOI: 10.1158/0008-5472.Can-05-0676  0.367
2004 Huusko P, Ponciano-Jackson D, Wolf M, Kiefer JA, Azorsa DO, Tuzmen S, Weaver D, Robbins C, Moses T, Allinen M, Hautaniemi S, Chen Y, Elkahloun A, Basik M, Bova GS, ... ... Trent JM, et al. Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer. Nature Genetics. 36: 979-83. PMID 15300251 DOI: 10.1038/Ng1408  0.364
2004 Qin JZ, Stennett L, Bacon P, Bodner B, Hendrix MJ, Seftor RE, Seftor EA, Margaryan NV, Pollock PM, Curtis A, Trent JM, Bennett F, Miele L, Nickoloff BJ. p53-independent NOXA induction overcomes apoptotic resistance of malignant melanomas. Molecular Cancer Therapeutics. 3: 895-902. PMID 15299072  0.329
2004 Guo Z, Linn JF, Wu G, Anzick SL, Eisenberger CF, Halachmi S, Cohen Y, Fomenkov A, Hoque MO, Okami K, Steiner G, Engles JM, Osada M, Moon C, Ratovitski E, ... Trent JM, et al. CDC91L1 (PIG-U) is a newly discovered oncogene in human bladder cancer. Nature Medicine. 10: 374-81. PMID 15034568 DOI: 10.1038/Nm1010  0.349
2004 Weeraratna AT, Becker D, Carr KM, Duray PH, Rosenblatt KP, Yang S, Chen Y, Bittner M, Strausberg RL, Riggins GJ, Wagner U, Kallioniemi OP, Trent JM, Morin PJ, Meltzer PS. Generation and analysis of melanoma SAGE libraries: SAGE advice on the melanoma transcriptome. Oncogene. 23: 2264-74. PMID 14755246 DOI: 10.1038/Sj.Onc.1207337  0.312
2003 Cohen-Solal KA, Sood R, Marin Y, Crespo-Carbone SM, Sinsimer D, Martino JJ, Robbins C, Makalowska I, Trent J, Chen S. Identification and characterization of mouse Rab32 by mRNA and protein expression analysis. Biochimica Et Biophysica Acta. 1651: 68-75. PMID 14499590 DOI: 10.1016/s1570-9639(03)00236-x  0.316
2003 Carr KM, Bittner M, Trent JM. Gene-expression profiling in human cutaneous melanoma. Oncogene. 22: 3076-80. PMID 12789283 DOI: 10.1038/sj.onc.1206448  0.32
2002 Weeraratna AT, Jiang Y, Hostetter G, Rosenblatt K, Duray P, Bittner M, Trent JM. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma Cancer Cell. 1: 279-288. PMID 12086864 DOI: 10.1016/S1535-6108(02)00045-4  0.352
2002 Seftor EA, Meltzer PS, Kirschmann DA, Pe'er J, Maniotis AJ, Trent JM, Folberg R, Hendrix MJ. Molecular determinants of human uveal melanoma invasion and metastasis. Clinical & Experimental Metastasis. 19: 233-46. PMID 12067204 DOI: 10.1023/A:1015591624171  0.367
2002 Shaheduzzaman S, Krishnan V, Petrovic A, Bittner M, Meltzer P, Trent J, Venkatesan S, Zeichner S. Effects of HIV-1 Nef on cellular gene expression profiles. Journal of Biomedical Science. 9: 82-96. PMID 11810028 DOI: 10.1007/Bf02256581  0.32
Show low-probability matches.